Cryocompression for CIPN

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

August 25, 2027

Study Completion Date

August 25, 2027

Conditions
Chemotherapy-induced Peripheral NeuropathyTaxane-Induced Peripheral NeuropathyCIPN - Chemotherapy-Induced Peripheral Neuropathy
Interventions
DEVICE

Paxman Limb Cryocompression System

An investigational device designed to provide controlled cooling and compression to participant limbs during chemotherapy administration. The device is comprised of a control unit, connecting hose, and two limb wraps. The customizable limb wraps delivers continuous-flow cooling-and-compression to participant extremities

Trial Locations (1)

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Paxman Coolers Limited

UNKNOWN

lead

Theresa Jabaley, PhD

OTHER

NCT07064798 - Cryocompression for CIPN | Biotech Hunter | Biotech Hunter